These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25190012)

  • 1. Analysis of biological therapeutic agents and biosimilars.
    Phinney K
    Anal Bioanal Chem; 2014 Oct; 406(26):6539. PubMed ID: 25190012
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in bioanalytical method validation for biologically derived macromolecules (biosimilars) compared with small molecules (generics).
    Oldfield P
    Bioanalysis; 2011 Jul; 3(14):1551-3. PubMed ID: 21756087
    [No Abstract]   [Full Text] [Related]  

  • 3. Analytical Aspects of Biopharmaceuticals and their Study by Mass Spectrometry.
    David V; Borbala D; Laroly V; Laszlo D; Istvan A; Imre K; Krisztina L
    Acta Pharm Hung; 2016; 86(4):141-150. PubMed ID: 29870600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A wide angle view of biosimilars from a bioanalytical perspective.
    Oldfield P
    Bioanalysis; 2013 Mar; 5(5):533-5. PubMed ID: 23425269
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioanalytical challenges of biosimilars.
    Islam R
    Bioanalysis; 2014 Feb; 6(3):349-56. PubMed ID: 24471955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and bioanalytical assay challenges to support comparability studies for biosimilar drug development.
    Cai XY; Wake A; Gouty D
    Bioanalysis; 2013 Mar; 5(5):517-20. PubMed ID: 23425265
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonclinical development of a biosimilar: the current landscape.
    O'Connor A; Rogge M
    Bioanalysis; 2013 Mar; 5(5):537-44. PubMed ID: 23425270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle sizing methods for the detection of protein aggregates in biopharmaceuticals.
    Khodabandehloo A; Chen DD
    Bioanalysis; 2017 Feb; 9(3):313-326. PubMed ID: 28098491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conference Report: Bioanalysis-related topics presented at the International Conference and Exhibition on Biowaivers and Biosimilars.
    Colletti KS
    Bioanalysis; 2013 Mar; 5(5):529-31. PubMed ID: 23425268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in bioanalytical assays for biosimilars.
    Wang X; Chen L
    Bioanalysis; 2014 Aug; 6(16):2111-3. PubMed ID: 25331854
    [No Abstract]   [Full Text] [Related]  

  • 11. Mini Focus: bioanalysis of biosimilars.
    Amaravadi L; Marini J
    Bioanalysis; 2013 Mar; 5(5):515-6. PubMed ID: 23425264
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.
    Lin JR; Chow SC; Chang CH; Lin YC; Liu JP
    Stat Med; 2013 Feb; 32(3):449-61. PubMed ID: 22911920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European perspective on biosimilars.
    Wadhwa M; Thorpe R
    Bioanalysis; 2013 Mar; 5(5):521-4. PubMed ID: 23425266
    [No Abstract]   [Full Text] [Related]  

  • 14. An adapted F-test for homogeneity of variability in follow-on biological products.
    Yang J; Zhang N; Chow SC; Chi E
    Stat Med; 2013 Feb; 32(3):415-23. PubMed ID: 22933180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quotient Bioresearch complete £1.5 million expansion of bioanalytical research facilities.
    King G
    Bioanalysis; 2012 Nov; 4(22):2666. PubMed ID: 23346559
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosimilars and reference biologics: decisions on biosimilar interchangeability require the involvement of dermatologists.
    Puig L
    Actas Dermosifiliogr; 2014 Jun; 105(5):435-7. PubMed ID: 24094515
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial for the special issue titled "Biopharmaceuticals 2020".
    Fekete S; Guillarme D
    J Pharm Biomed Anal; 2020 May; 183():113198. PubMed ID: 32113748
    [No Abstract]   [Full Text] [Related]  

  • 18. Biosimilars: the 'future' of biologic therapy?
    Ranjan N; Mahajan VK; Misra M
    J Dermatolog Treat; 2011 Dec; 22(6):319-22. PubMed ID: 20666673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of biosimilars: an evolving landscape.
    Subramanyam M
    Bioanalysis; 2013 Mar; 5(5):575-86. PubMed ID: 23425273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development.
    Thway TM; Wang YM; Booth BP; Maxfield K; Huang SM; Zineh I
    AAPS J; 2019 Dec; 22(1):15. PubMed ID: 31858313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.